Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Mizolastine

Mizolastine

pharmaceutical raw materials
Mizolastine structure

Mizolastine 

structure
  • CAS No:

    108612-45-9

  • Formula:

    C24H25FN6O

  • Chemical Name:

    Mizolastine

  • Synonyms:

    4(3H)-Pyrimidinone,2-[[1-[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-;4(1H)-Pyrimidinone,2-[[1-[1-[(4-fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-;2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-4(3H)-pyrimidinone;Mizolastine;MKC 431;SL 850324;Zolistan;Mistamine;Mizollen;2-[[1-[1-[(4-Fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

White SolidMizolastine was marketed in Germany and Switzerland as Mizollen for the symptomatic relief of seasonal and perennial allergic rhinoconjunctivitis and urticaria. Mizolastine is a new long-acting, orally active antihistaminic agent with a rapid onset of action ; the two most recent H1 antagonists launched were fexofenadine, metabolite of terfenadine (Sepracor, 1996) and Olopatadine (Kyowa Hakko, 1997). Mizolastine can be prepared in 2 steps from 2-chloro 1- (4-fluorobenzyl)benzim


Mizolastine is a member of benzimidazoles.|Mizolastine is under investigation in clinical trial NCT01928316 (A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers).

Mizolastine Basic Attributes

432.49

432.49

1308068-626-2

244O1F90NA

DTXSID5046801

R06AX25|R - Respiratory system

2933990090

Characteristics

65.8

3.42

1.34±0.1 g/cm3(Predicted)

217°

1.682

Safety Information

UW7481284

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P312, P322, P330, P363, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)

Mistalin

Mizolastine Use and Manufacturing

Allergic rhinitis;Blocking H1 receptors

Computed Properties

Molecular Weight:432.5
XLogP3:3.2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:5
Exact Mass:432.20738760
Monoisotopic Mass:432.20738760
Topological Polar Surface Area:65.8
Heavy Atom Count:32
Complexity:728
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

2-[[[1-[(4-Fluorophenyl)methyl]-1H-benzoimidazol-2-yl]-4-piperidinyl]methyl-amino]-4(3H)-pyrimidinone

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • Opella Healthcare Shanghai Ltd

    China China
    Active
  • Shenyang Sanjiu Pharmaceutical Co., Ltd.

    China China
    Active
  • Beijing Jialin Pharmaceutical Co., Ltd.

    China China
    Active

Recommended Suppliers of Mizolastine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.